Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B3 | P37058 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.30 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | DRD2 | P14416 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
| ▸ | DRD1 | P21728 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14735951 | 0.90 | TP53 (0.33) | HSD17B3CYP2A6 | |
| SCHEMBL14735918 | 0.82 | MAPT (0.36) | HTR2A | |
| SCHEMBL14752301 | 0.63 | HSD17B3 (0.37) | HSD17B3CYP2A6CHRM2CHRM4CHRM5 | |
| SCHEMBL7799447 | 0.62 | — | — | |
| SCHEMBL16598160 | 0.62 | MAPT (0.64) | HSD17B3CYP2A6CHRM2CHRM4CHRM5 | |
| SCHEMBL8121328 | 0.62 | ACHE (0.50) | CYP2A6CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL11753432 | 0.61 | HSD17B3 (0.35) | HSD17B3CYP2A6HTR2A | |
| SCHEMBL9206858 | 0.60 | S100A4 (0.41) | HSD17B3CYP2A6CHRM2CHRM1DRD2 | |
| SCHEMBL22301865 | 0.58 | HSD17B3 (0.33) | HSD17B3CYP2A6 | |
| SCHEMBL14603342 | 0.58 | MEN1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130059996-A1 | Boron-Containing PI-Electron Materials Incorporating Formally Aromatic and Neutral Borepin Rings | THE JOHNS HOPKINS UNIVERSITY | 2013-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130059996-A1 | Boron-Containing PI-Electron Materials Incorporating Formally Aromatic and Neutral Borepin Rings | PNN, CIAPIN1, VNN1 | HSD17B3 3735/4885CYP2A6 1437/4885CHRM2 1469/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.